Cadonilimabcisplatinpaclitaxelnab-paclitaxeltaxaneESCCadvanced esophageal squamous cell carcinoma (ESCC)chemotherapy
…erse events were reported in 53.5% (23/43) patients.Conclusions Cadonilimab combined with taxane and cisplatin as first-line treatment reve…